Viewing Study NCT05155033

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 3:01 AM

Ignite Modification Date: 2026-01-01 @ 5:21 AM

Study NCT ID: NCT05155033

Status: RECRUITING

Last Update Posted: 2025-08-11

First Post: 2021-12-10

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Sponsor: National Cancer Institute (NCI)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module